medicine-news-1/kta-capital-advises-springtree-global-investors-on-an-au-247-2-million-investment-in-healthlinx-ltd--58917-1/;/a><br
| We're sorry, that page (http://www.bio-medicine.org/medicine-news-1/kta-capital-advises-springtree-global-investors-on-an-au-247-2-million-investment-in-healthlinx-ltd--58917-1/;/a><br) was not found. Search medicine news 1 kta capital advises springtree global investors on an au 247 2 million investment in healthlinx ltd 58917 1 ; a><br at Google Search medicine news 1 kta capital advises springtree global investors on an au 247 2 million investment in healthlinx ltd 58917 1 ; a><br at Yahoo Search medicine news 1 kta capital advises springtree global investors on an au 247 2 million investment in healthlinx ltd 58917 1 ; a><br at Msn |
(Date:11/30/2009)..., NEW YORK, Nov. 30 Th...ch (MJFF) today announced $1.5 million in total aw...ntially disease-modifying therapies for Parkinson,...l Approaches to Drug Discovery for Parkinson,s Dis...Corporation, plc (NYSE: ELN ), a neuroscience-ba...
(Date:11/30/2009)..., AMSTERDAM, November 30 Biop...y that the first patients have been enrolled in it...TIR(TM). The study is,designed to show reduction i...r following an allogeneic stem cell transplantatio...od cancer patients eligible for an allogeneic,stem...
(Date:11/30/2009)..., ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCall/ ...it has completed enrollment in the Phase II clinic.../2009 recommended strains) VLP vaccine candidate i...dults). This randomized, double-blind, active-con...y and immunogenicity of two different doses (15 mc...
(Date:11/30/2009)... , SEATTLE, Nov. 30 ...IC) announced today that its new class of platinum..., demonstrated a stronger anti-tumor potency and a...ased compounds as well as the ability to overcome ...sults were presented in a paper titled "Novel Bis-...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3[0] The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments[0] Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)[0] NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults[0] New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents
(Date:12/1/2009)... /PRNewswire-Asia-FirstCall/ -- China Biologic,Pro...BPO ) ("China Biologic," or,the "Company"), one of...ies in,China, today announced that the Company has... NASDAQ Global Market. , China Biologic e...n,Wednesday, December 2, 2009, until which time it...
(Date:12/1/2009)...swire/ -- Tibotec Therapeutics, a division of Cent... that it is launching a new initiative to raise aw...lor living with HIV/AIDS. Through a comprehensive ... outreach and a new Web site, www.TheGraceStudy.c...CE study, the largest clinical trial in North Amer...
(Date:12/1/2009)...ire/ -- ,, Overweight Children May Develop Bac...m The Children,s Hospital at Montefiore in New Yor...be causing damage to their spines. Researchers rev...etween the ages of 12 and 20 who complained of bac...-year period. The results showed an association be...
Breaking Medicine Technology:China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7Tuesday, Dec. 1: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Tuesday, Dec. 1: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3How Do Our Attitudes About Beauty Change As We Age 3F 53481 1How Do Our Attitudes About Beauty Change As We Age 3F 53481 2How Do Our Attitudes About Beauty Change As We Age 3F 53481 3How Do Our Attitudes About Beauty Change As We Age 3F 53481 4PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 1PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 2New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records 28EMR 29 Directly at the Point of Care 53477 1New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records 28EMR 29 Directly at the Point of Care 53477 2New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records 28EMR 29 Directly at the Point of Care 53477 3| Copyright © 2003-2007 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |